Press Releases

Investors

Press Releases

 
Press Releases
  Date Title and Summary View
Nov 16, 2011
PASADENA, Calif. — November 16, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, today announced the implementation of a 1-for-10 reverse stock split of its common stock. Trading on a post-split basis will begin Novem...
Nov 14, 2011
HOUSTON, TX — November 14, 2011 — Leonardo Biosystems, Inc., an emerging drug delivery company, announced today that it has received the second half of a $2.5 million award from the Texas Emerging Technology Fund (TETF). The initial investment tranche was received in April 2010. Leonardo was founded based on the...
Nov 10, 2011
PASADENA, Calif. — November 10, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, today announced the publication of data from Ablaris Therapeutics, Inc.'s lead drug candidate, Adipotide™, demonstrating weight los...
Nov 3, 2011
PASADENA, Calif. — November 3, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, today announced that it has appointed Brendan P. Rae, Ph.D., J.D., to the position of Chief Business Officer, effective November 1, 2011. ...
Nov 2, 2011
PASADENA, Calif. — November 2, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR) today announced that a paper further validating the drug development programs of Ablaris Therapeutics, Inc., a subsidiary of Arrowhead, and Alvos Therapeutics, Inc., was published in the Proceedings of the National Academy of Sciences (...
Oct 27, 2011
PASADENA, Calif. — October 27, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has appointed Bruce Given, M.D. to the position of Chief Operating Officer of the Company effective October 26, 2011. Since February 1, 2010, Dr. Given has served as Chief Executive Officer of Leonardo Biosystems,...
Oct 24, 2011
PASADENA, Calif. – October 24, 2011 – Arrowhead Research Corporation (NASDAQ: ARWR), today announced that it has acquired RNA therapeutics assets from Roche (SIX: RO, ROG; OTCQX: RHHBY) including the state-of-the-art research site in Madison, WI. "This acquisition is transformational for us and important to the broader RNAi f...
Oct 4, 2011
PASADENA, Calif. - October 4, 2011 - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that on September 30, 2011, it closed a private placement of approximately 14.5 million shares of common stock priced at market for $0.38 per share. Gross proceeds were approximately $5.5 million and will be used to fund current operations. ...
Aug 8, 2011
PASADENA, Calif. — August 8, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, today announced financial results for its fiscal 2011 third quarter ended June 30, 2011.  “In recent months our focus has been on advan...
Aug 1, 2011
PASADENA, Calif. — August 1, 2011 — Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2011 third quarter ended June 30, 2011, on Monday, August 8, 2011 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 1-800-860-2442...
Page: FirstPrevious ...
21
NextLast
= add release to Briefcase